Extent of change of significantly altered genes from cell growth, maintenance, and signal transduction ontologies p value represents WKY vs. SHR comparisons.
| WKY-Based | SHR-Based | p | |
|---|---|---|---|
| Isoproterenol | |||
| Decreasers | –0.09 ± 0.02 (n = 8) | –0.10 ± 0.02 (n = 11) | N.S. |
| Increasers | 0.28 ± 0.11 (n = 20) | 0.04 ± 0.14 (n = 17) | <0.05 |
| Forskolin | |||
| Decreasers | –0.10 ± 0.02 (n = 11) | –0.14 ± 0.05 (n = 11) | N.S. |
| Increasers | 0.32 ± 0.16 (n = 38) | –0.28 ± 0.26 (n = 22) | <0.05 |
WKY-based, (WKYISO/WKYCONTROL) – (SHRISO/SHRCONTROL) or (WKYFSK/WKYCONTROL) – (SHRFSK/SHRCONTROL). SHR-based, (SHRISO/SHRCONTROL) – (WKYISO/WKYCONTROL) or (SHRFSK/SHRCONTROL) – (WKYFSK/WKYCONTROL).
N.S., not significant.